What Patients Know About Weight-Loss Drugs and How They Might Affect Their Households in a City Health System

Patients' knowledge about glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is currently limited.

• There is a lack of understanding among patients regarding the prescribing indications and side effects of GLP-1 RAs.
• Current methods of learning about GLP-1 RAs may be inadequate for patients' needs.
• Patients may have preferences for different ways to learn about GLP-1 RAs.
• The impact of GLP-1 RA use on weight-related behaviors and household attitudes, such as food purchasing patterns, is not well understood.

Simplified